• Home
  • Cancer Care
  • Research
  • Education & Training
  • About Us
  • Giving
  • News
  • Locations
  • Jobs
  • Calendar
Memorial Sloan-Kettering Cancer Center
Find Faculty &
Laboratory Staff
  • About Our Research
  • Research Programs & Departments
  • Research Resources
  • Pre- and Postdoctoral Training
  • Career Opportunities

About Our Research

  • Mission & History
  • Research Calendar
  • Research Locations
  • Paul Marks Prize for Cancer Research
  • President's Seminars

Research Programs & Departments

  • Sloan-Kettering Institute
  • Memorial Hospital Research
  • Clinical Research
  • Collaborative Research Centers

Research Resources

  • Office of Technology Development
  • Research & Technology Management
  • Core Facilities
  • Library

Pre- and Postdoctoral Training

  • PhD & MD/PhD Education
  • Postdoctoral Research Training

Career Opportunities

  • Careers at Memorial Sloan-Kettering Cancer Center
  • Sloan-Kettering Institute
  • Human Oncology & Pathogenesis Program
  • Epidemiology & Biostatistics
Back to Sloan-Kettering Institute: Research Programs
Sloan-Kettering Institute // Samuel Danishefsky

Samuel Danishefsky: Epothilones

Enlarge Image

Publications

A. Rivkin, T.-C. Chou, S. J. Danishefsky. On the Remarkable Properties of Fludelone: How We Got There. Angew. Chim. Int. Ed. 44, 2838-2850 (2005).

Y. S. Cho, K.-D. Wu, M. A. S. Moore, T.-C. Chou, S. J. Danishefsky. Second-Generation Epothilones: Discovery of Fludelone and its Extraordinary Antitumor Properties. Drugs of the Future 30, 737-745 (2005).

K.-D. Wu, Y. S. Cho, J. Katz, V. Ponomarev, S. Chen-Kiang, S. J. Danishefsky, M. A.S. Moore. Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. Proc. Nat. Acad. Sci. USA 102 10640-10645 (2005).

H. Dong, X. Zhang, W.P. Tong, S.J. Danishefsky, T.C. Chou. Therapeutic Cure against Human Tumor Xenografts in Nude Mice by a Microtubule Stablilization Agent, Fludelone, via Parental or Oral Route. Cancer Research. 65, 9445-9454. (2005).

Back to Projects
Glossary Print Download E-mail ShareFacebookFacebook
TwitterTwitter
LinkedInLinkedIn
  • Molecular Pharmacology & Chemistry
  • Samuel Danishefsky
    • Projects
      • Carbohydrate-based Antitumor Vaccines
      • Fully Synthetic, Homogeneous Erythropoietin
      • Cytotoxic Natural Products
      • Epothilones
      • Radicicol
      • UCS1025A
      • Neurotrophically Active Small Molecules
    • Lab Members
    • Career Opportunities
Home>Research>Research Programs & Departments>Molecular Pharmacology & Chemistry>Samuel Danishefsky>Projects
About Our Research
  • Mission & History
  • Research Calendar
  • Research Locations
  • Paul Marks Prize for Cancer Research
  • President's Seminars
Research Programs & Departments
  • Sloan-Kettering Institute
  • Memorial Hospital Research
  • Clinical Research
  • Collaborative Research Centers
Research Resources
  • Office of Technology Development
  • Research & Technology Management
  • Core Facilities
  • Library
Pre- and Postdoctoral Training
  • PhD & MD/PhD Education
  • Postdoctoral Research Training
Career Opportunities
  • Careers at Memorial Sloan-Kettering Cancer Center
  • Sloan-Kettering Institute
  • Human Oncology & Pathogenesis Program
  • Epidemiology & Biostatistics
About Memorial
Sloan-Kettering
  • Learn More
  • Contact Us
  • Find Faculty & Lab Staff
Facebook Twitter LinkedIn
RSS Feeds Podcasts YouTube
Memorial Sloan-Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan-Kettering Institute
Gerstner Sloan-Kettering Graduate School of Biomedical Sciences | Memorial Sloan-Kettering Cancer Center Library

Legal Disclaimer | Privacy Practices | Public Notices
Inside MSKCC | ©2012 Memorial Sloan-Kettering Cancer Center